Shimon Sakaguchi

Shimon Sakaguchi (坂口 志文, Sakaguchi Shimon, born January 19, 1951) is an immunologist and a Distinguished Professor of Osaka University.[1] He is best known for the discovery of regulatory T cells and to describe their role in the immune system. This discovery is used in the treatment of cancer and autoimmune diseases.

Shimon Sakaguchi
坂口 志文
Born (1951-01-19) January 19, 1951
Shiga Prefecture, Japan
EducationKyoto University MD (1976)
Ph.D (1982)
Known forRegulatory T cells
AwardsWilliam B. Coley Award (2004)
Gairdner Foundation International Award (2015)
Crafoord Prize (2017)
Robert Koch Prize (2020)
Scientific career
FieldsPathology, immunology
InstitutionsJohns Hopkins University
Stanford University
Scripps Research Institute
RIKEN
University of Tokyo
Osaka University

Biography

Sakaguchi was born in Japan's Shiga Prefecture and educated at Kyoto University.

In 2015, the news agency Thomson Reuters signals Shimon Sakaguchi among potential recipients of the Nobel Prize in Physiology or Medicine.[2]

Awards and recognition
at the Royal Ontario Museum on October 29, 2015

References
  1. "Experimental Immunology – Osaka University Immunology Frontier Research Center". IFReC | Osaka University Immunology Frontier Research Center. Retrieved 1 May 2021.
  2. Announcing the 2015 Citation Laureates by Thomson Reuters.
  3. William B. Coley Award-Award, Cancer Research Institute (cancerresearch.org)
  4. The 2008 Keio Medical Science Prize Awardees, Keiō University
  5. "Distinguished Professor Shimon SAKAGUCHI of IFReC awarded Canada Gairdner International Award". Osaka University. March 26, 2015.
  6. The Asahi Prize Asahi Shimbun
  7. Shimon Sakaguchi National Academy of Sciences
  8. Shimon Sakaguchi MD, PhD, Gairdner Foundation
  9. "News & Topics | Osaka University Immunology Frontier Research Center".
  10. "Goethe-Universität —". www.uni-frankfurt.de.
  11. "Robert Koch Stiftung – Shimon Sakaguchi". www.robert-koch-stiftung.de.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.